Aphria Inc (CVE:APH) – Analysts at Clarus Securities issued their Q2 2017 EPS estimates for Aphria in a research report issued to clients and investors on Tuesday. Clarus Securities analyst N. Atkinson forecasts that the brokerage will post earnings per share of $0.01 for the quarter. Clarus Securities also issued estimates for Aphria’s FY2017 earnings at $0.02 EPS and FY2018 earnings at $0.14 EPS.
Aphria Company Profile
Aphria Inc, formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company’s retail sales are primarily sold through the Company’s online store, as well as telephone orders. Its wholesale shipments are sold to other Medical Purposes Regulations (MMPR) Licensed Producers.
Receive News & Ratings for Aphria Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria Inc and related companies with MarketBeat.com's FREE daily email newsletter.